How to rank parameters and choose "the best"?
|
|
8
|
247
|
January 4, 2025
|
Summary table of different Cox PHM models to compare them
|
|
7
|
586
|
December 23, 2024
|
How to use parameters of different measurement times?
|
|
3
|
207
|
December 18, 2024
|
RMS Cox PH Model
|
|
51
|
4271
|
November 21, 2024
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
6
|
7929
|
November 5, 2024
|
RMS Case Study in Cox Regression
|
|
4
|
16170
|
September 28, 2024
|
Dynamic regression for survival analysis
|
|
0
|
447
|
September 18, 2024
|
Andersen-Gill - multistate and time varying covariate
|
|
6
|
711
|
August 27, 2024
|
C-index with clustered data
|
|
1
|
567
|
August 8, 2024
|
Marginal Structural Models
|
|
2
|
518
|
July 25, 2024
|
Progression in cancer trials
|
|
26
|
4824
|
June 25, 2024
|
External validation of a time-to-event prognostic model
|
|
2
|
945
|
May 2, 2024
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
873
|
April 17, 2024
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
8
|
1215
|
March 24, 2024
|
Validate and calibrate Cox model on dataset with a categorical covariate with few observations
|
|
2
|
967
|
March 21, 2024
|
External Validation and Calibration of Cox model
|
|
13
|
6709
|
March 12, 2024
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
665
|
March 10, 2024
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
871
|
February 23, 2024
|
Time to pre-randomization monthly seizure count
|
|
1
|
777
|
February 8, 2024
|
Creating a Nomogram with Multiply Imputed Datasets
|
|
1
|
993
|
January 31, 2024
|
Use of cpower function in Hmisc package
|
|
4
|
1191
|
January 9, 2024
|
Calculating fraction of new information in Cox proportional hazard models
|
|
17
|
2026
|
December 14, 2023
|
Combining HR from same study sub-groups for meta-analysis
|
|
0
|
831
|
November 28, 2023
|
Immortal time bias
|
|
2
|
869
|
October 29, 2023
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
1170
|
October 3, 2023
|
ROC has a S shape, why?
|
|
30
|
5221
|
August 25, 2023
|
Time-to-event analysis with a blocking factor
|
|
3
|
1008
|
August 14, 2023
|
Survival analysis vs. nested case-control analysis
|
|
3
|
1562
|
August 14, 2023
|
External validation or a bigger modelling sample?
|
|
9
|
2176
|
August 12, 2023
|
RMS Case Study in Parametric Survival Modeling
|
|
0
|
12156
|
September 17, 2021
|